Lyell Wealth Management, LP Amgen Inc Transaction History

Lyell Wealth Management, LP

$978 Million
Q1 2024

A detailed history of Lyell Wealth Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Lyell Wealth Management, LP holds 2,883 shares of AMGN stock, worth $927,374. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,883

Previous 2,856 0.95%

Holding current value

$927,374

Previous $822,000 0.36%

% of portfolio

0.08%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $7,259 - $8,763	27 Added 0.95%	2,883 $819,000
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $3,835 - $4,326	-15 Reduced 0.52%	2,856 $822,000
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $12,856 - $15,202	-60 Reduced 2.05%	2,871 $637,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $97,992 - $119,436	-434 Reduced 12.9%	2,931 $708,000
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $13,741 - $17,460	60 Added 1.82%	3,365 $0

Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $97,191 - $109,613	433 Added 15.08%	3,305 $745,000
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $9,228 - $10,269	40 Added 1.41%	2,872 $699,000
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $1,315 - $1,455	-6 Reduced 0.21%	2,832 $685,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $41,764 - $47,796	-210 Reduced 6.89%	2,838 $638,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $60,709 - $71,128	-286 Reduced 8.58%	3,048 $648,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $80,117 - $88,885	-343 Reduced 9.33%	3,334 $813,000
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $130,926 - $152,574	590 Added 19.11%	3,677 $915,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $135,237 - $161,043	625 Added 25.39%	3,087 $710,000
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $103,480 - $115,078	441 Added 21.82%	2,462 $626,000
Q2 2020 Jul 30, 2020	BUY	$197.81 - $242.74 $2,175 - $2,670	11 Added 0.55%	2,021 $477,000
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $37,842 - $48,640	200 Added 11.05%	2,010 $485,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $1.27 Million - $1.52 Million	-7,266 Reduced 80.06%	1,810 $350,000
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $1.6 Million - $1.88 Million	-9,608 Reduced 51.42%	9,076 $1.67 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $113,224 - $127,628	626 Added 3.47%	18,684 $3.55 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $128,983 - $150,564	723 Added 4.17%	18,058 $3.52 Million
Q3 2018 Oct 30, 2018	BUY	$185.29 - $208.89 $716,145 - $807,359	3,865 Added 28.69%	17,335 $3.59 Million
Q2 2018 Jul 30, 2018	BUY	$166.05 - $186.51 $2,490 - $2,797	15 Added 0.11%	13,470 $2.49 Million
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $42,357 - $49,500	250 Added 1.89%	13,455 $2.29 Million
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $33,758 - $37,718	-200 Reduced 1.49%	13,205 $2.3 Million
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $2.24 Million - $2.56 Million	13,405	13,405 $2.5 Million

Others Institutions Holding AMGN

# of Institutions

2,939

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lyell Wealth Management, LP with notifications on news.

Account

Lyell Wealth Management, LP Amgen Inc Transaction History